Data from clinical investigations of FMT have shown that after 6 weeks of FMT intervention, lean-donor FMT can help MetS participants lose weight (including visceral fat), improve insulin resistance and peripheral insulin sensitivity, and lower subjects' blood pressure (Mocanu et al., 2021). The gene discussed is INS; the disease is Insulin resistance.